Drug re-purposing to improve outcomes in the management of prostate cancer – aims, outcome measures and design of current phase III trials

Abstract Prostate cancer remains a major cause of cancer morbidity and mortality and is rising in incidence across the world. Although a succession of randomised controlled trials have improved outcomes across all stages of disease, there remain significant clinical challenges and unmet needs. Repur...

Descripció completa

Dades bibliogràfiques

Autors principals:	Duncan C. Gilbert, Ruth E. Langley, Dami Ayadi, Mannab Berhanu, Lakshmi Kowdley Hemanth, Seunghee Kwon, Hossameldin Abdallah, Angela Meade, Noel Clarke, Silke Gillessen, Nicholas James, Gauthier Bouche, Mahesh Parmar, Matthew Nankivell, Laura Murphy
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-01-01
Col·lecció:	BMC Pharmacology and Toxicology
Accés en línia:	https://doi.org/10.1186/s40360-025-01077-w
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!